NJ State Employees Deferred Compensation Plan’s Boston Scientific BSX Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-43,600	Closed	-$4.26M	–	60
2025 Q3	$4.26M	Sell	43,600 -3,400	-7%	-$352K	0.47%	42
2025 Q2	$5.05M	Hold	47,000	–	–	0.6%	32
2025 Q1	$4.74M	Hold	47,000	–	–	0.61%	28
2024 Q4	$4.2M	Sell	47,000 -8,000	-15%	-$704K	0.51%	39
2024 Q3	$4.61M	Hold	55,000	–	–	0.55%	35
2024 Q2	$4.24M	Hold	55,000	–	–	0.53%	32
2024 Q1	$3.77M	Hold	55,000	–	–	0.48%	42
2023 Q4	$3.18M	Hold	55,000	–	–	0.44%	50
2023 Q3	$2.9M	Hold	55,000	–	–	0.44%	52
2023 Q2	$2.97M	Hold	55,000	–	–	0.43%	52
2023 Q1	$2.75M	Buy	55,000 +19,000	+53%	+$895K	0.42%	57
2022 Q4	$1.67M	Hold	36,000	–	–	0.27%	95
2022 Q3	$1.39M	Hold	36,000	–	–	0.24%	105
2022 Q2	$1.34M	Hold	36,000	–	–	0.22%	110
2022 Q1	$1.59M	Hold	36,000	–	–	0.22%	110
2021 Q4	$1.53M	Hold	36,000	–	–	0.19%	122
2021 Q3	$1.56M	Hold	36,000	–	–	0.21%	115
2021 Q2	$1.54M	Hold	36,000	–	–	0.2%	114
2021 Q1	$1.39M	Hold	36,000	–	–	0.2%	121
2020 Q4	$1.29M	Hold	36,000	–	–	0.2%	118
2020 Q3	$1.38M	Hold	36,000	–	–	0.25%	94
2020 Q2	$1.26M	Hold	36,000	–	–	0.24%	92
2020 Q1	$1.18M	Hold	36,000	–	–	0.27%	92
2019 Q4	$1.63M	Hold	36,000	–	–	0.28%	87
2019 Q3	$1.47M	Hold	36,000	–	–	0.27%	87
2019 Q2	$1.55M	Hold	36,000	–	–	0.28%	89
2019 Q1	$1.38M	Sell	36,000 -4,000	-10%	-$153K	0.25%	93
2018 Q4	$1.41M	Hold	40,000	–	–	0.29%	84
2018 Q3	$1.54M	Hold	40,000	–	–	0.26%	89
2018 Q2	$1.31M	Hold	40,000	–	–	0.23%	101
2018 Q1	$1.09M	Hold	40,000	–	–	0.19%	123
2017 Q4	$992K	Hold	40,000	–	–	0.17%	153
2017 Q3	$1.17M	Hold	40,000	–	–	0.21%	123
2017 Q2	$1.11M	Hold	40,000	–	–	0.21%	156
2017 Q1	$995K	Hold	40,000	–	–	0.19%	180
2016 Q4	$865K	Hold	40,000	–	–	0.17%	200
2016 Q3	$952K	Hold	40,000	–	–	0.2%	179
2016 Q2	$935K	Hold	40,000	–	–	0.2%	171
2016 Q1	$782K	Hold	40,000	–	–	0.17%	207
2015 Q4	$738K	Hold	40,000	–	–	0.15%	221
2015 Q3	$656K	Hold	40,000	–	–	0.14%	231
2015 Q2	$708K	Hold	40,000	–	–	0.14%	242
2015 Q1	$710K	Hold	40,000	–	–	0.14%	247
2014 Q4	$530K	Hold	40,000	–	–	0.1%	285
2014 Q3	$472K	Hold	40,000	–	–	0.1%	292
2014 Q2	$511K	Hold	40,000	–	–	0.1%	297
2014 Q1	$541K	Hold	40,000	–	–	0.11%	292
2013 Q4	$481K	Hold	40,000	–	–	0.1%	306
2013 Q3	$470K	Hold	40,000	–	–	0.1%	302
2013 Q2	$371K	Buy	+40,000	New	+$339K	0.08%	322

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

NJ State Employees Deferred Compensation Plan's BSX Position: Q4 2025 in Review

NJ State Employees Deferred Compensation Plan sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 43,600 shares — an estimated $4.26M sold.

NJ State Employees Deferred Compensation Plan first reported a position in BSX in Q2 2013 and held it in 50 quarters. The position peaked at $5.05M in Q2 2025. 1,791 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

NJ State Employees Deferred Compensation Plan reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 43,600 Boston Scientific shares in Q4 2025, an estimated $4.26M.
NJ State Employees Deferred Compensation Plan first reported a position in Boston Scientific in Q2 2013 and held it in 50 quarters.
NJ State Employees Deferred Compensation Plan's Boston Scientific position peaked at $5.05M in Q2 2025.
1,791 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2025.